Beijing StarMab BioMed Technology Ltd. (StarMab) has entered a research evaluation agreement with Lonza, a global development and manufacturing partner to biopharma. The agreement gives StarMab access to Lonza’s XS® Pichia Expression System Toolbox to develop their proprietary multifunctional VHH antibodies.  
Content Type: Article
Latest content

Latest briefing from the Knowledge Center